SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
83
|
Cardiovascular Disease in HIV Patients: An Emerging Paradigm and Call to Action
Steven Grinspoon
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
The Price of Selling Sex: HIV Among Female Sex Workers—The Context and the Public Health Response
Frances M. Cowan
University College London, London, United Kingdom
Moderator
Edgar T. Overton
University of Alabama at Birmingham, Birmingham, AL, United States
Statin Therapy Reduces Coronary Noncalcified Plaque Volume in HIV Patients: A Randomized Controlled Trial
Janet Lo
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
Rosuvastatin Arrests Progression of Carotid Intima-Media Thickness in Treated HIV
Grace A. McComsey
Case Western Reserve University, Cleveland, OH, United States
Calcified Plaque Burden Is Associated With Serum Gut Microbiota-Generated TMA in HIV
Suman Srinivasa
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
Varenicline vs Placebo for Smoking Cessation: ANRS 144 Inter-ACTIV Randomized Trial
Patrick Mercie
Hosp. Saint-André, Bordeaux, France
Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors
Grace A. McComsey
Case Western Reserve University, Cleveland, OH, United States
Fracture Prediction With Modified FRAX in Older HIV+ and HIV- Men
Michael T. Yin
Columbia University Medical Center, New York, NY, United States
Exposure to Antiretrovirals (ARVs) and Development of Chronic Kidney Disease (CKD)
Amanda Mocroft
University College London, London, United Kingdom
Renal and Bone Safety of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate
Paul E. Sax
Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
Special Presentation: Update on National Heart, Lung, and Blood Institute High-Impact AIDS Research
Monica Shah
National Heart, Lung, and Blood Institute, Bethesda, MD, United States
The Burden of Liver Disease Among Persons With Hepatitis C in the United States
Monina Klevens
US Centers for Disease Control and Prevention, Atlanta, GA, United States
High Efficacy of Daclatasvir/Asunaprevir/PR in HIV/HCV1-4 Null Responders (ANRS HC30)
Lionel Piroth
CHU Dijon, Dijon, France
High SVR Regardless of Time to Suppression With ABT-450/r/Ombitasvir & Dasabuvir+RBV
David Wyles
University of California San Diego, La Jolla, CA, United States
The Paradox of Highly Effective Sofosbuvir Combo Therapy Despite Slow Viral Decline
Jérémie Guedj
IAME, UMR 1137, Inserm, F-75018; Univ Paris Diderot, Sorbonne Paris Cité, F-75018, Paris, France
Real-World Pharmaceutical Costs in the Simeprevir/Sofosbuvir Era: $164,485 per SVR4
Kian Bichoupan
Mount Sinai School of Medicine, New York, NY, United States
Impact of Deferring HCV Treatment on Liver-Related Events in HIV+ Patients
Cindy Zahnd
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
Daclatasvir in Combination With Sofosbuvir for HIV/HCV Coinfection: ALLY-2 Study
David Wyles
University of California San Diego, La Jolla, CA, United States
Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1
Susanna Naggie
Duke Clinical Research Institute, Durham, NC, United States
Passively Acquired ADCC Activity in HIV-Infected Infants Correlates With Survival
Caitlin Milligan
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States
AAV-Expressed eCD4-Ig Protects Rhesus Macaques From Multiple SHIV-AD8 Challenges
Michael Farzan
The Scripps Research Institute, Jupiter, FL, United States
HIV Neutralizing Antibodies Induced by Native-Like Envelope Trimers
Rogier Sanders
Academic Medical Center University of Amsterdam, Amsterdam, Netherlands
Efficacy Loss of BnAbs During HIV-1 Cell-Cell Spread Is Strain- and Epitope-Dependent
Lucia Reh
University of Zurich, Zurich, Switzerland
Peripheral T Follicular Helper Cells With Universal Helper Activity in HIV Infection
Hendrik Streeck
US Military HIV Research Program, Silver Spring, MD, United States
Redirected Killing of HIV-Infected T Cells by Germinal Center CD8 T Cells
Constantinos Petrovas
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States
IL-21 Reduces Inflammation and Virus Persistence in ART-Treated SIV-Infected Macaques
Luca Micci
Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States
Discovery of CD8+ T Cell Epitopes Encoded by the HIV 5' Leader Sequence
Edward Kreider
University of Pennsylvania, Philadelphia, PA, United States
Neutralizing Antibodies Differ Between HIV-1–Infected RV144 Vaccinees and Placebos
Shelly J. Krebs
US Military HIV Research Program, Silver Spring, MD, United States
Population Viral Load in Three High HIV Prevalence Settings in Sub-Saharan Africa
David Maman
Epicentre/Médecins Sans Frontières, Paris, France
Disparities in Engagement Within HIV Care in South Africa
Simbarashe Takuva
National Institute for Communicable Diseases, NHLS, Johannesburg, South Africa
Decentralizing Access to Antiretroviral Therapy Services for Adults in Swaziland
Andrew F. Auld
US Centers for Disease Control and Prevention, Atlanta, GA, United States
Who Are the 10-Year AIDS Survivors on Antiretroviral Therapy in Haiti?
Samuel Pierre
Les Centres GHESKIO, Port-au-Prince, Haiti
Nationwide Evaluation of Antiretroviral Therapy Coverage on Prevention in Rwanda: A Multisectional Time-Trend Analysis.
Sabin Nsanzimana
Rwanda Biomedical Centre, Kigali, Rwanda
Impact of Male Circumcision Scale-Up on Community-Level HIV Incidence in Rakai, Uganda
Xiangrong Kong
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
Effects of Antiretroviral Treatment on Health Care Utilization in Rural South Africa
Jan A. Hontelez
Erasmus University Medical Center, Nijmegen, Netherlands
The Impact of PEPFAR Abstinence and Faithfulness Funding Upon HIV Risk Behaviors in Sub-Saharan Africa
Nathan C. Lo
Stanford University School of Medicine, Stanford, CA, United States
The Impact of Antiretroviral Therapy on Adult Life Expectancy in Sub-Saharan Africa
Georges Reniers
London School of Hygiene and Tropical Medicine, London, United Kingdom
Discussion Leader
Nina Friis-Moller
Odense University Hospital, Odense, Denmark
Cumulative HIV Care Measures Highly Associated With Acute Myocardial Infarction
Jorge L. Salinas
Emory University, Atlanta, GA, United States
Cardiovascular Disease Risk Prediction in the HIV Outpatient Study (HOPS)
Kenneth A. Lichtenstein
National Jewish Health, Denver, CO, United States
Incidence and Risk of Myocardial Infarction (MI) by Type in the NA-ACCORD
Daniel R. Drozd
University of Washington, Seattle, WA, United States
HIV-Infected Veterans and the New ACC/AHA Cholesterol Guidelines: Got Statins?
Meredith E. Clement
Duke University, Durham, NC, United States
Evaluation of the ACC/AHA CVD Risk Prediction Algorithm Among HIV-Infected Patients
Virginia A. Triant
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
Discussion Leader
Michael Busch
Blood Systems Research Institute, San Francisco, CA, United States
A Generalized Entropy Measure of Viral Diversity for Identifying Recent HIV-1 Infections
Julia W. Wu
Harvard School of Public Health, Boston, MA, United States
Viral Load is Critical in Limiting False-Recent Results From HIV Incidence Assays
Alex Welte
South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa
False Recent Rates for Two Recent Infection Testing Algorithms, South Nyanza, Kenya
Clement Zeh
US Centers for Disease Control and Prevention, Kisumu, Kenya
The Effect of HIV-1 Subtype A, C and D on Cross-Sectional Incidence Assay Performance
Oliver B. Laeyendecker
National Institute of Allergy and Infectious Diseases, Baltimore, MD, United States
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
83
|
